Comparison of Conventional With Sonography Assisted Breast Surgery After Neoadjuvant Chemotherapy
Sonographically Assisted Versus Conventionally Breast Surgery in Breast Cancer Patients With an Indication for Breast Conserving Surgery After Neoadjuvant Chemotherapy
1 other identifier
interventional
137
1 country
1
Brief Summary
Aim of the study is to investigate whether intra-surgical visualisation of malignoma reduces the resection rate in the case of R1 resection compared to the procedure without sonographic visualisation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 16, 2018
CompletedFirst Posted
Study publicly available on registry
November 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2023
CompletedFebruary 14, 2024
February 1, 2024
4.3 years
October 16, 2018
February 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
R0 resection rate
proportion of surgical procedures for cancer in which the surgeon is able to completely remove all detectable tumor tissue with negative margins, indicating that no cancer cells remain in the surgical site
3 years
Secondary Outcomes (2)
Weight of primary resedate
3 years
Time for cut and sew
During surgery
Study Arms (2)
Sonographically assisted breast surgery
EXPERIMENTALSonography assisted breast surgery
Conventional breast surgery
ACTIVE COMPARATORConventional breast surgery
Interventions
Sonography
Conventional
Eligibility Criteria
You may qualify if:
- to 80 years
- Female
- Presurgical validated breast cancer
- Unifocal to multifocal findings
- Palpable and/o non-palpable findings
- Neoadjuvant chemotherapy
- Indication for breast conserving therapy
- General operation ability and anesthesia ability
- Consent to conventional breast conserving breast surgery with wire marking
- Ability and will to follow the study conditions
- Written declaration of consent after clarification
You may not qualify if:
- Sonographically not clearly delineate resection areal
- Simultaneous participation in other interventional trials that interfere with this study at the investigator's discretion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department for Women's Health
Tübingen, Baden-Wurttemberg, 72086, Germany
Study Officials
- PRINCIPAL INVESTIGATOR
Markus Hahn, Prof. Dr.
Department of Women's Health, University Hospital Tuebingen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2018
First Posted
November 9, 2018
Study Start
October 1, 2018
Primary Completion
January 1, 2023
Study Completion
January 1, 2023
Last Updated
February 14, 2024
Record last verified: 2024-02